Patienter koinficeret med hepatitis B - og/ eller hepatitis C- virus Patienter med kronisk aktiv hepatitis B - og/ eller hepatitis C- koinfektion fik adgang til at deltage i fase III- undersøgelser (N=113/ 699 eller 16, 2%; HBV=6%, HCV=9%, HBV+HCV=1%), forudsat at prøverne vedrørende ASAT, ALAT og alkalisk phosphatase ikke oversteg 5 gange den øvre normalgrænse.
Patients co-infected with hepatitis B and/ or hepatitis C virus In Phase III studies, patients with chronic active hepatitis B and/ or hepatitis C co-infection (N = 113/ 699 or 16.2%; HBV=6%, HCV=9%, HBV+HCV=1%) were permitted to enrol provided that AST, ALT, and alkaline phosphatase tests did not exceed 5 times the upper limit of normal.